CSGCA - CIC - UNAM

The AXA Research Fund Scientific Board composed of international renowned academic and business experts oversees the applicant selection process. It validates the eligibility and selection criteria as well as the tools used to process the call for applications. The president of the Scientific Board, by delegation of the Board, acts as a jury over and decides upon the recommendations of funding based on:

Scientific assessments of applications (“light proposals” & “full proposals”) performed by a network of international academic experts (review panel members & remote referees);

Public engagement interviews by non-academic AXA experts. Interviews results are used to make a difference only if it is in favor of the candidate.

The AXA Research Fund partners with the European Science Foundation (ESF) to carry out the evaluation process. ESF is an established, independent and non-governmental organization dedicated to support science operation. ESF operates the review relying on the criteria defined by the AXA Research Fund.

To know more about the AXA Research Fund: http://axa-research.org/   

To know more about the European Science Foundation: http://www.esf.org/

 2. Eligibility criteria

 Host institution

The AXA Research Fund partners with academic institutions only. Host institutions must be registered within the AXA Research Fund’s database and located within the geographical scope below:

 NB: Please note that this geographical scope is reviewed on a yearly basis.

  Research Project

Applications must be written in English, submitted through the on-line submission system before the relevant deadline and complete i.e. all elements forming the application (information requested on-line and documents listed below). The research project must fall within the scope of the mission of the AXA Research Fund as described below. The mission of the AXA Research Fund is to fund basic science dedicated to a better understanding of global risks related to:

 Environmental risks

- Climate change; glacier retreat, sea-level rise, extreme events...;

- Natural hazards: earthquake, atmospheric & space-weather phenomena…;

- Human driven environmental changes: urban pollution, nanotechnologies, pesticide exposure…) ;

 Life risks

- Aging & long term care: trends in individual longevity, age-related diseases, population demographics, public policies…;

- Biomedical risks: infectious diseases and pandemics, exposure to new technologies…;

- Addictions and risky behaviors: psychology, biology, medicine...;

 Socio-economic Risks

- Geopolitical risks: access to natural resources, international and civil conflicts, political upheavals, international security…;

- Macro-economic and financial systemic risks: all uncertainties pertaining to relationships between economic aggregates (e.g. national income, government expenditure, aggregate demand)…;

- Individual and collective behaviors relating to uncertainty & risky practices;

- Large corporate risks: internal corporate governance risks, threats and challenges inherent to the corporate environment….;

- Digital risks: cybersecurity threats, Big Data related risks…

 Please note that the AXA Research Fund does not fund:

 “Research & Development” programs when they pursue an objective of systematic application of knowledge or understanding, directed towards the production of useful materials, devices, and systems or methods, including design, development, and improvement of prototypes and new processes to meet specific requirements. This includes specific technology development, as well as clinical trials. Please note that translational research is not considered ineligible as long as the research work conducted is mainly fundamental.

  Research that would breach the AXA Group ethical guidelines, which includes (but is not limited to):

- Research violating national regulations;

- Research having direct military use;

- Research having potentially dangerous environmental impacts;

- Research relying on the artificial production of highly infectious pathogens with potential for large scale harmful/lethal effects for humans and research involving gain of function;

- Biomedical research conducted without the fully informed consent of the participant;

- Research on embryonic stem cells (incl. animal, with inferred subsequent human application);

- Research processing private personal data without the informed consent of the concerned parties (incl. genetic information);

- Research activities aiming at human cloning.

 NB: It is the applicants’ responsibility to identify any potential ethics issues, to handle the ethics aspects of their proposal, and to detail how they plan to address them. Please refer to this page for more information on the AXA Group Compliance and Ethics Guide (http://www.axa.com/en/responsibility/shareholders-esg-risk-management/business-ethics/).

  Projects that are already underway as the AXA Research Fund wishes to finance projects from start to finish.

 Any project falling under one of the above listed “non-fundable” categories will be considered ineligible.

Cases of scientific misconduct such as fabrication, falsification, plagiarism or misrepresentation of data will be considered as breaches of fundamental ethical principles and the proposals concerned will be excluded

https://secure-researchfund.axa.com/Default.aspx.

https://www.axa-research.org/sites/dev/files/A-Howtoobtain-Modus/Modus_Operandi_PDF_2016_FINAL.pdf.